The prevalence of motor delay among HIV infected children living in Cape Town, South Africa

International Journal of Rehabilitation Research

Volumn 32, Issue 2, 2009, Pages 108-114

  Ferguson, Gillian ^a   Jelsma, Jennifer ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

Author keywords

Antiretroviral therapy; Child development; HIV; Resource poor setting

Indexed keywords

ANTIRETROVIRAL; ANTIRETROVIRAL THERAPY; CAPE TOWN , SOUTH AFRICA; CENTRAL NERVOUS SYSTEMS; CHILD DEVELOPMENT; DEVELOPMENTAL DELAY; EMPLOYMENT STATUS; HIV; HIV INFECTION; HOSPITAL ADMISSIONS; INFANT DEVELOPMENT; MEAN AGES; MOTOR PERFORMANCE; OPPORTUNISTIC INFECTIONS; RESOURCE POOR SETTING; SOCIAL ENVIRONMENT; SOCIO-ECONOMIC STATUS;

ECONOMICS;

MOTORS;

ARTICLE; BAYLEY SCALES OF INFANT DEVELOPMENT SECOND EDITION; CAREGIVER; CHILD; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; MALE; MOTOR DEVELOPMENT; MOTOR DYSFUNCTION; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; RATING SCALE; SOUTH AFRICA;

ANTI-HIV AGENTS; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DEVELOPMENTAL DISABILITIES; FEMALE; HIV INFECTIONS; HUMANS; INFANT; MALE; MOTOR SKILLS; PREVALENCE; PSYCHOMOTOR PERFORMANCE; SOCIAL CLASS; SOUTH AFRICA; URBAN POPULATION;

EID: 67650873415     PISSN: 03425282     EISSN: None     Source Type: Journal    
DOI: 10.1097/MRR.0b013e3283013b34     Document Type: Article

References (20)

1. Aylward EH, Butz AM, Hutton N, Joyner ML, Vogelhut JW (1992). Cognitive and motor development in infants at risk for human immunodeficiency virus. Am J Dis Child 146:218-222.
2. Bayley N (1993). Bayley scales of infant development manual. 2nd ed. Texas: The Psychological Corporation.
3. Belman A, Muenz L, Marcus JC, Goedert JJ, Landesman S, Rubinstein A, et al. (1996). Neurologic status of human immunodeficiency virus type 1 infected infants and their controls: a prospective study from birth to 2 years. Pediatrics 98:1109-1118. (Pubitemid 26399274)
4. Besser M (2004). Antiretroviral therapy in pregnancyyand so much more. Paper presented at the PACTG: Management of Paediatric and Perinatal HIV infection in the era of antiretroviral therapy, Cape Town, South Africa.
5. Bruck I, Tahan TT, da Cruz CR, Martins LTF, Antoniuk SA, Rodrigues M, et al. (2001). Developmental milestones of vertically infected HIV infected and seroreverters children. Arquivos de Neuro-Psiquiatria 59:691-695.
6. Chase C, Ware J, Hittelman J, Blasini I, Smith R, Llorente A, et al. (2000). Early cognitive and motor development among infants born to women infected with human immunodeficiency virus. Pediatrics 106:e25.
7. Department of Health (2006). National HIV and syphilis antenatal seroprevalence survey in South Africa 2005: South African National Department of Health.
8. Gay CL, Armstrong FD, Cohen D, Lai S, Hardy MD, Swales TP, et al. (1995). The effects of HIV on cognitive and motor development in children born to HIVseropositive women with no reported drug use: birth to 24 months. Pediatrics 96:1078-1082.
9. Ioannidis JPA, Tatsioni A, Abrams EJ, Bulterys M, Coombs RW, Goedert JJ, et al. (2004). Maternal viral load and rate of disease progression among vertically HIV-1 infected children: an international meta-analysis. AIDS 18:99-108. (Pubitemid 38402323)
10. Mintz M (1998). Clinical features of HIV infection in children. In: Gendelman HE, Lipton SA, Epstein L, Swindells S, editors. The neurology of AIDS. New York: Chapman and Hall; pp. 385-407.
11. Mitchell W (2001). Neurological and developmental effects of HIV and AIDS in children and adolescents. Ment Retard Dev Disabil Res Rev 7:211-216.
12. Msellati P, Lepage P, Hitimana DG, van Goethem C, van de Perre P, Dabis F (1993). Neurodevelopmental testing of children born to human immunodeficiency virus type 1 seropositive, seronegative mothers: a prospective cohort study in Kigali, Rwanda. Pediatrics 92:843-848. (Pubitemid 23351141)
13. Nozyce M, Hittleman J, Muenz L, Durako S, Fischer M, Willoughby A (1994). Effects of perinatally acquired human immunodeficiency virus infection on neurodevelopment in children in the first two years of life. Pediatrics 94:883-981. (Pubitemid 24359193)
14. Potterton JL, Eales CJ (2001). Prevalence of developmental delay in infants who are HIV positive. S Afr J Physiother 27:11-15.
15. Sanchez-Ramon S, Resino S, Bellon Cano JM, Ramos JT, Gurbindo D, Munoz-Fernandez A (2003). Neuroprotective effects of early antiretrovirals in vertical HIV infection. Pediatr Neurol 29:218-221. (Pubitemid 37415253)
16. Sharland M, Castelli Gattinara di Zub G, Ramos JT, Blanche S, Gibb DM (2002). PENTA guidelines for the use of antiretroviral therapy in paediatric HIV infection. HIV Med 3:215-226. (Pubitemid 34905555)
17. Smith R, Malee K, Charurat M, Magder L, Mellins C, MacMillan C, et al. (2000). Timing of perinatal human immunodeficiency virus type 1 infection and rate of neurodevelopment. Pediatr Infect Dis J 19:862-871.
18. Spiegel HML, Bonwit AM (2002). HIV infection in children. In: Batshaw ML, editor. Children with disabilities. 5th ed. Baltimore: Paul Brookes Publishing Company; pp. 123-138.
19. Wolters PL, Brouwers P (1998). Evaluation of neurodevelopmental deficits in children with HIV infection. In: Gendelman HE, Lipton SA, Epstein L, Swindells S, editors. The neurology of AIDS. New York: Chapman and Hall; pp. 425-442.
20. World Health Organization (2004). Report on the global AIDS epidemic. Geneva: UNAIDS.